PATH | VRL
Menu

Protein Carriers of Conjugate Vaccines: Characteristics, Development and Clinical trials

This article, published in Human Vaccines & Immunotherapeutics, discusses the conjugate vaccines for preventing infections caused by Haemophilus influenzae type b, Streptococcus pneumoniae, and Neisseria meningitidis. It specifically reviews the characteristics of the proteins used in the construction of the vaccines including CRM, tetanus toxoid, diphtheria toxoid, Neisseria meningitidis outer membrane complex, and Haemophilus influenzae protein D.

Author: Pichichero ME

Published: 2013

» Visit web page (English)

(Located at www.landesbioscience.com)

Citation: Pichichero ME. Protein Carriers of Conjugate Vaccines: Characteristics, Development and Clinical trials. Human Vaccines & Immunotherapeutics. 2013;9(12). Early Online Publication.

Resource types: Peer-reviewed journal

Diseases/vaccines: Haemophilus influenzae type b (Hib), Meningococcus, Pneumococcus

Topics: Disease/vaccine specific information

Regions: Global